Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-20,471
Closed -$1.54M – 546
2023
Q3
$1.54M Sell
20,471
-20,000
-49% -$1.49M 0.03% 277
2023
Q2
$2.88M Sell
40,471
-12,267
-23% -$704K 0.06% 198
2023
Q1
$2.64M Buy
52,738
+6,511
+14% +$316K 0.06% 228
2022
Q4
$2.02M Buy
46,227
+13,535
+41% +$668K 0.04% 465
2022
Q3
$1.74M Sell
32,692
-7,800
-19% -$403K 0.02% 662
2022
Q2
$1.84M Buy
40,492
+31,337
+342% +$1.49M 0.02% 672
2022
Q1
$529K Buy
+9,155
New +$484K 0.01% 744

Other funds holding GKOS

UBS O'Connor's GKOS Position: Q4 2023 in Review

UBS O'Connor sold out of Glaukos (GKOS) in Q4 2023, closing a stake of 20,471 shares — an estimated $1.54M sold.

UBS O'Connor first reported a position in GKOS in Q1 2022 and held it in 7 quarters. The position peaked at $2.88M in Q2 2023. 246 funds tracked by Wall St. Rank hold GKOS as of Q4 2023.

  • UBS O'Connor reported no remaining Glaukos position as of Q4 2023 after selling out during the quarter.
  • UBS O'Connor sold 20,471 Glaukos shares in Q4 2023, an estimated $1.54M.
  • UBS O'Connor first reported a position in Glaukos in Q1 2022 and held it in 7 quarters.
  • UBS O'Connor's Glaukos position peaked at $2.88M in Q2 2023.
  • 246 funds tracked by Wall St. Rank held Glaukos as of Q4 2023.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.